Darlington, United Kingdom

Stephen Taylor

This inventor holds 2 USPTO granted patents. Top assignee: Astra Aktiebolag. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Taylor. Retrieved from https://idiyas.com/inventor/stephen-taylor-8demaofi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Stephen Taylor

Introduction

Stephen Taylor is a notable inventor based in Darlington, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of active compounds. With a total of 2 patents to his name, Taylor's work has had a meaningful impact on the industry.

Latest Patents

Among his latest patents is a method for the preparation of pharmaceutically active compounds by biooxidation. This innovative approach allows for the efficient synthesis of enantiomeric compounds, which are crucial in the development of effective medications.

Career Highlights

Stephen Taylor is currently employed at Astra Aktiebolag, a company known for its commitment to advancing healthcare through innovative solutions. His work at Astra has positioned him as a key player in the pharmaceutical sector, where he continues to push the boundaries of drug development.

Collaborations

Throughout his career, Taylor has collaborated with esteemed colleagues such as Robert Holt and Per Lennart Lindberg. These partnerships have fostered a collaborative environment that enhances the quality and scope of his research.

Conclusion

In summary, Stephen Taylor's contributions to pharmaceutical innovation through his patents and collaborations highlight his importance in the field. His work continues to influence the development of new and effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…